Literature DB >> 10097127

Ontogeny of T cell tolerance to peripherally expressed antigens.

D J Morgan1, C Kurts, H T Kreuwel, K L Holst, W R Heath, L A Sherman.   

Abstract

Transgenic expression of the influenza virus hemagglutinin (HA) in the pancreatic islet beta cells of InsHA mice leads to peripheral tolerance of HA-specific T cells. To examine the onset of tolerance, InsHA mice were immunized with influenza virus A/PR/8 at different ages, and the presence of nontolerant T cells was determined by the induction of autoimmune diabetes. The data revealed a neonatal period wherein T cells were not tolerant and influenza virus infection led to HA-specific beta cell destruction and autoimmune diabetes. The ability to induce autoimmunity gradually waned, such that adult mice were profoundly tolerant to viral HA and were protected from diabetes. Because cross-presentation of islet antigens by professional antigen-presenting cells had been reported to induce peripheral tolerance, the temporal relationship between tolerance induction and activation of HA-specific T cells in the lymph nodes draining the pancreas was examined. In tolerant adult mice, but not in 1-week-old neonates, activation and proliferation of HA-specific CD8(+) T cells occurred in the pancreatic lymph nodes. Thus, lack of tolerance in the perinatal period correlated with lack of activation of antigen-specific CD8(+) T cells. This work provides evidence for the developmental regulation of peripheral tolerance induction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10097127      PMCID: PMC22384          DOI: 10.1073/pnas.96.7.3854

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Antigen-presenting cells for CD8+ T cells.

Authors:  J Sprent; M Schaefer
Journal:  Immunol Rev       Date:  1990-10       Impact factor: 12.988

2.  Induction of neonatal tolerance to Mlsa antigens by CD8+ T cells.

Authors:  S R Webb; J Sprent
Journal:  Science       Date:  1990-06-29       Impact factor: 47.728

3.  Ontogeny of priming of cytotoxic T cells to minor alloantigens: the development of direct priming precedes that of cross-priming.

Authors:  E Rafii-Tabar; A A Czitrom
Journal:  Eur J Immunol       Date:  1986-08       Impact factor: 5.532

4.  Antigenic hybrids of influenza A viruses with surface antigens to order.

Authors:  R G Webster
Journal:  Virology       Date:  1970-11       Impact factor: 3.616

5.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

6.  Ontogeny of murine accessory cells: Ia antigen expression and accessory cell function in in vitro primary antibody responses.

Authors:  P I Nadler; R J Klingenstein; R J Hodes
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

7.  Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes.

Authors:  P Kisielow; H Blüthmann; U D Staerz; M Steinmetz; H von Boehmer
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

8.  Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.

Authors:  F R Carbone; M J Bevan
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

9.  Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.

Authors:  F R Carbone; M J Bevan
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes.

Authors:  P Höglund; J Mintern; C Waltzinger; W Heath; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

View more
  26 in total

Review 1.  The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs.

Authors:  Shannon J Turley; Anne L Fletcher; Kutlu G Elpek
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

2.  Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.

Authors:  Joanne M Fraser; Claire N Janicki; Ben J E Raveney; David J Morgan
Journal:  Immunology       Date:  2006-06-23       Impact factor: 7.397

3.  Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen.

Authors:  Amy D Higgins; Marianne A Mihalyo; Adam J Adler
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

Review 4.  Animal models of human type 1 diabetes.

Authors:  Matthias von Herrath; Gerald T Nepom
Journal:  Nat Immunol       Date:  2009-02       Impact factor: 25.606

5.  Enhanced CD8 T cell cross-presentation by macrophages with targeted disruption of STAT3.

Authors:  Jason Brayer; Fengdong Cheng; Hongwei Wang; Pedro Horna; Ildefonso Vicente-Suarez; Javier Pinilla-Ibarz; Eduardo M Sotomayor
Journal:  Immunol Lett       Date:  2010-03-25       Impact factor: 3.685

6.  Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy.

Authors:  Rolf Billeskov; Yichuan Wang; Shahram Solaymani-Mohammadi; Blake Frey; Shweta Kulkarni; Peter Andersen; Else Marie Agger; Yongjun Sui; Jay A Berzofsky
Journal:  J Immunol       Date:  2017-03-27       Impact factor: 5.422

Review 7.  Self-tolerance and the composition of T cell repertoire.

Authors:  L A Sherman; D J Morgan; C T Nugent; F J Hernandez; H T Kreuwel; A Murtaza; A Ko; J Biggs
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

8.  CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose.

Authors:  C Kurts; R M Sutherland; G Davey; M Li; A M Lew; E Blanas; F R Carbone; J F Miller; W R Heath
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

9.  Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells.

Authors:  Trevor Smith; Xiaotian Lin; Marielle Mello; Kristi Marquardt; Jocelyn Cheung; Binfeng Lu; Linda A Sherman; Grégory Verdeil
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

10.  In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.

Authors:  Marianne A Mihalyo; Amy D H Doody; Jeremy P McAleer; Elizabeth C Nowak; Meixiao Long; Yi Yang; Adam J Adler
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.